{"entity":{"id":"src-asco-post","kind":"collection","name":"The ASCO Post","aka":[],"tldr":"The ASCO Post gives reliable, clinician-written summaries of the trials that matter, usually within days.","summary":"The ASCO Post carries news and expert commentary on trials, approvals, guidelines and oncology leadership, with clinician-written summaries of the trials that matter usually appearing within days. It is published by Harborside with ASCO, printing twice monthly and publishing daily online, and is free to read. It offers a good balance of data and expert perspective, and its congress coverage is thorough. On OnCo it is listed as a source with the tags source and news.","asOf":"2026-09-08","links":[{"label":"The ASCO Post","url":"https://ascopost.com/"}],"tags":["source","news"],"related":[],"cancers":[],"sections":[],"technologies":[],"targets":[],"drugs":[],"companies":[],"institutions":[],"pathways":[],"terms":[],"trials":[],"people":[],"bottlenecks":[],"keyPapers":[],"journals":[],"dependsOn":[],"notes":[],"url":"https://ascopost.com/","holds":"News and expert commentary on trials, approvals, guidelines, and oncology leadership.","license":"Free","maintainer":"Harborside / ASCO"},"route":"/collections/src-asco-post/","neighbours":{"trial":[{"id":"emerald-3","kind":"trial","name":"EMERALD-3","route":"/trials/emerald-3/"},{"id":"keynote-b96","kind":"trial","name":"KEYNOTE-B96 / ENGOT-ov65","route":"/trials/keynote-b96/"},{"id":"komet-001","kind":"trial","name":"KOMET-001","route":"/trials/komet-001/"},{"id":"serena-6","kind":"trial","name":"SERENA-6","route":"/trials/serena-6/"}],"institution":[{"id":"asco","kind":"institution","name":"American Society of Clinical Oncology (ASCO)","route":"/institutions/asco/"}]}}